Cartesian Therapeutics In... (RNAC)
10.11
-1.25 (-11.00%)
At close: Apr 10, 2025, 1:07 PM
Cartesian Therapeutics Revenue
Cartesian Therapeutics reported an annual revenue of $38.91M, reflecting a 49.64% growth. For the quarter ending December 31, 2024, Cartesian Therapeutics generated -$759K in revenue.
Revenue (ttm)
$38.91M
Revenue Growth
49.64%
Price / Sales Ratio
71.39
Revenue / Employee
$589.59K
Employees
66
Market Cap
261.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 38.91M | +49.64% |
| Dec 31, 2023 | 26M | -76.53% |
| Dec 31, 2022 | 110.78M | +30.21% |
| Dec 31, 2021 | 85.08M | +412.60% |
| Dec 31, 2020 | 16.6M | n/a |